Scientists launch Largest-Ever study to unravel Cystinosis's Long-Term effects

NCT ID NCT07680751

First seen Jul 02, 2026 · Last updated Jul 02, 2026

Summary

This study follows 250 people with cystinosis, a rare genetic disorder that causes a buildup of the amino acid cystine, leading to damage in the kidneys, eyes, and other organs. Researchers will track how the disease progresses over time, including kidney function, eye problems, and quality of life, while also collecting blood samples for future research. The goal is to better understand the long-term course of the disease under current treatments and identify factors that may predict complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could reveal better ways to manage cystinosis and identify biomarkers that predict complications, potentially improving long-term care.
What could go wrong
As an observational study, it does not test a new treatment, so it cannot directly lead to a cure or new therapy. Results may take years to influence clinical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CYSTINOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AP-HP_ Hôpital Charles Foix

    Ivry-sur-Seine, Île-de-France Region, 94200, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.